Rheumatoid Studies

In a 1992 Harvard Medical Study, Collagen Type II that is derived from chicken sternum cartilage was proven to help rebuild damaged joints, cartilage, and tendons. Sixty patients with severe, active rheumatoid arthritis were given either Collagen, Type II, or a placebo. It was noted that a decrease in the number of swollen and tender joints occurred in those who received Collagen Type II for the three-month duration of the trial but not those who received a placebo. Four patients in the collagen group had complete remission of the disease. No side effects were evident. This data demonstrates the clinical efficacy of an oral tolerization approach for rheumatoid arthritis. Among its many advantages, Collagen Type II is more effective in addressing immune-system-related forms of arthritis (i.e. rheumatoid) and possesses the highest concentration of anti-inflammatory and joint suppressing proteoglycans; boasting an absorption rate of 70-90 percent, as compared to only 8 to 10 percent for Sulphate.